EDGAR HTML

United States

Securities and Exchange Commission

Washington, D.C. 20549

Form N-CSR

Certified Shareholder Report of Registered Management Investment Companies

811-8519

(Investment Company Act File Number)

Federated Hermes Core Trust

______________________________________________________________

(Exact Name of Registrant as Specified in Charter)

Federated Hermes Funds

4000 Ericsson Drive

Warrendale, PA 15086-7561

(Address of Principal Executive Offices)

(412) 288-1900

(Registrant's Telephone Number)

Peter J. Germain, Esquire

1001 Liberty Avenue

Pittsburgh, Pennsylvania 15222-3779

(Name and Address of Agent for Service)

(Notices should be sent to the Agent for Service)

Date of Fiscal Year End: 06/30/2024

Date of Reporting Period: Six months ended 12/31/23

Item 1.

Reports to Stockholders

Semi-Annual Shareholder Report

December 31, 2023

Bank Loan Core Fund

A Portfolio of Federated Hermes Core Trust

Not FDIC Insured ▪ May Lose Value ▪ No Bank Guarantee

Portfolio of Investments

December 31, 2023 (unaudited)

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—86.3%
		Aerospace/Defense—0.7%
$ 3,180,561		TransDigm, Inc., 2023 Term Loan I–1st Lien, 8.598% (SOFR CME +3.250%), 8/24/2028	$ 3,190,987
		Airlines—0.7%
1,450,000		American Airlines, Inc., 2021 Term Loan–1st Lien, 10.427% (SOFR CME +4.750%), 4/20/2028	1,491,803
700,000		SkyMiles IP Ltd., 2020 Skymiles Term Loan B–1st Lien, 9.166% (SOFR CME +3.750%), 10/20/2027	717,864
790,928		United Airlines, Inc., 2021 Term Loan B–1st Lien, 9.220% (SOFR CME +3.750%), 4/21/2028	792,845
		TOTAL	3,002,512
		Automotive—1.9%
2,500,000		Clarios Global, LP, 2023 Incremental Term Loan–1st Lien, 9.106% (SOFR CME +3.750%), 5/6/2030	2,502,478
2,200,756		DexKo Global, Inc., 2021 USD Term Loan B–1st Lien, 9.360% (SOFR CME +3.750%), 10/4/2028	2,186,938
500,000		DexKo Global, Inc., 2023 Incremental Term Loan–1st Lien, 9.598% (SOFR CME +4.250%), 10/4/2028	500,000
1,950,000		RealTruck Group, Inc., 2021 Term Loan B–1st Lien, 8.970% (SOFR CME +3.500%), 1/31/2028	1,923,926
1,321,172		TI Group Automotive Systems, LLC, 2021 USD Term Loan–1st Lien, 8.720% (SOFR CME +3.250%), 12/16/2026	1,323,378
		TOTAL	8,436,720
		Building Materials—3.9%
1,440,000		American Builders & Contractors Supply Co., Inc., 2019 Term Loan–1st Lien, 7.356% (SOFR CME +2.000%), 1/15/2027	1,441,636
1,702,900		Cornerstone Building Brands, Inc., 2021 Term Loan B–1st Lien, 8.712% (SOFR CME +3.250%), 4/12/2028	1,701,897
1,889,049		CP Atlas Buyer, Inc., 2021 Term Loan B–1st Lien, 9.206% (SOFR CME +3.750%), 11/23/2027	1,858,614
2,401,793		Foundation Building Materials Holding Co., LLC, 2021 Term Loan–1st Lien, 8.895% (SOFR CME +3.250%), 1/31/2028	2,391,985
1,446,268		Icebox Holdco III, Inc., 2021 1st Lien Term Loan–1st Lien, 9.110% (SOFR CME +3.500%), 12/22/2028	1,435,023
1,160,000		Icebox Holdco III, Inc., 2021 2nd Lien Term Loan–2nd Lien, 12.360% (SOFR CME +6.750%), 12/21/2029	1,061,400
1,451,364		SRS Distribution, Inc., 2021 Term Loan B–1st Lien, 8.970% (SOFR CME +3.500%), 6/2/2028	1,455,602
1,580,977		SRS Distribution, Inc., 2022 Incremental Term Loan–1st Lien, 8.956% (SOFR CME +3.500%), 6/2/2028	1,583,451
1,900,000		Tecta America Corp., 2023 Term Loan B–1st Lien, 9.720% (SOFR CME +4.250%), 4/10/2028	1,902,954
2,397,226		White Cap Buyer, LLC, Term Loan B–1st Lien, 9.106% (SOFR CME +3.750%), 10/19/2027	2,405,221
		TOTAL	17,237,783
		Cable Satellite—2.5%
1,816,843		Charter Communications Operating, LLC, 2019 Term Loan B2–1st Lien, 7.133% (SOFR CME +1.750%), 2/1/2027	1,814,386
1,000,000		Charter Communications Operating, LLC, 2023 Term Loan B4–1st Lien, 7.360% (SOFR CME +2.000%), 12/7/2030	998,260
1,257,759		DirecTV Financing, LLC, Term Loan–1st Lien, 10.650% (SOFR CME +5.000%), 8/2/2027	1,225,468
2,000,000		UPC Financing Partnership, 2021 USD Term Loan AX–1st Lien, 8.476% (SOFR CME +3.000%), 1/31/2029	1,996,460
3,500,000		Virgin Media Bristol, LLC, 2023 USD Term Loan Y–1st Lien, 8.790% (SOFR CME +3.250%), 3/31/2031	3,493,437
1,500,000		Ziggo Financing Partnership, USD Term Loan I–1st Lien, 7.976% (SOFR CME +2.500%), 4/30/2028	1,498,395
		TOTAL	11,026,406
		Chemicals—4.4%
1,253,271		Axalta Coating Systems U.S. Holdings, Inc., 2023 USD Term Loan B4–1st Lien, 7.848% (SOFR CME +2.500%), 12/20/2029	1,255,899
1,910,011		Element Solutions, Inc., 2023 Term Loan B–1st Lien, 7.356% (SOFR CME +2.000%), 12/18/2030	1,917,174
995,000		H.B. Fuller Co., 2023 Term Loan B–1st Lien, 7.606% (SOFR CME +2.250%), 2/15/2030	997,090
1,514,455		Illuminate Buyer, LLC, 2021 Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 6/30/2027	1,515,001
3,341,625		Koppers, Inc., First Lien Term Loan B–1st Lien, 8.960% (SOFR CME +3.500%), 4/10/2030	3,362,510
2,146,931		Lonza Group AG, USD Term Loan B–1st Lien, 9.373% (SOFR CME +3.925%), 7/3/2028	1,949,894
2,448,314		Olympus Water US Holding Corp., 2021 USD Term Loan B–1st Lien, 9.360% (SOFR CME +3.750%), 11/9/2028	2,440,558
975,000		Olympus Water US Holding Corp., 2023 Incremental Term Loan–1st Lien, 10.348% (SOFR CME +5.000%), 11/9/2028	979,453
1,881,976		Potters Industries, LLC, Term Loan B–1st Lien, 9.448% (SOFR CME +4.000%), 12/14/2027	1,885,953
1,450,000		PQ Corp., 2021 Term Loan B–1st Lien, 7.983% (SOFR CME +2.500%), 6/9/2028	1,454,176
1,491,373		Sparta U.S. HoldCo., LLC, 2021 Term Loan–1st Lien, 8.705% (SOFR CME +3.250%), 8/2/2028	1,487,586
		TOTAL	19,245,294

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—continued
		Consumer Cyclical Services—3.0%
$ 1,519,329		Allied Universal Holdco, LLC, 2021 USD Incremental Term Loan B–1st Lien, 9.206% (SOFR CME +3.750%), 5/12/2028	$ 1,511,529
2,800,000		Allied Universal Holdco, LLC, 2023 Term Loan B–1st Lien, 10.106% (SOFR CME +4.750%), 5/12/2028	2,799,326
2,090,222		AP Core Holdings II, LLC, Amortization Term Loan B1–1st Lien, 10.970% (SOFR CME +5.500%), 9/1/2027	2,022,543
1,895,250		Belron Finance US, LLC, 2023 Term Loan–1st Lien, 7.995% (SOFR CME +2.500%), 4/18/2029	1,896,408
1,971,025		Core & Main, LP, 2021 Term Loan B–1st Lien, 7.955% (SOFR CME +2.500%), 7/27/2028	1,974,720
3,221,523		Garda World Security Corp., 2021 Term Loan B–1st Lien, 9.725% (SOFR CME +4.250%), 10/30/2026	3,231,349
		TOTAL	13,435,875
		Consumer Products—2.3%
1,925,033		BCPE Empire Holdings, Inc., 2023 Extended Term Loan–1st Lien, 10.106% (SOFR CME +4.750%), 12/11/2028	1,927,774
1,500,000		CNT Holdings I Corp., 2020 2nd Lien Term Loan–2nd Lien, 12.176% (SOFR CME +6.750%), 11/6/2028	1,507,973
1,166,475		CNT Holdings I Corp., 2020 Term Loan–1st Lien, 8.926% (SOFR CME +3.500%), 11/8/2027	1,167,201
1,737,534		Energizer Holdings, Inc., 2020 Term Loan–1st Lien, 7.721% (SOFR CME +2.250%), 12/22/2027	1,739,705
1,000,000		Illuminate Merger Sub Corp., 1st Lien Term Loan–1st Lien, 8.610% (SOFR CME +3.000%), 7/21/2028	992,468
1,000,000		Illuminate Merger Sub Corp., 2nd Lien Term Loan–2nd Lien, 12.360% (SOFR CME +6.750%), 7/23/2029	966,255
1,895,919		Sunshine Luxembourg VII S.a.r.l., 2021 USD Term Loan B3–1st Lien, 8.948% (SOFR CME +3.500%), 10/1/2026	1,903,388
		TOTAL	10,204,764
		Diversified—0.4%
1,000,000		Pre-Paid Legal Services, Inc., 2021 2nd Lien Term Loan–2nd Lien, 12.470% (SOFR CME +7.000%), 12/14/2029	915,000
985,000		Pre-Paid Legal Services, Inc., 2021 Term Loan–1st Lien, 9.220% (SOFR CME +3.750%), 12/15/2028	977,283
		TOTAL	1,892,283
		Diversified Manufacturing—1.7%
2,005,963		Emrld Borrower, LP, Term Loan B–1st Lien, 8.356% (SOFR CME +3.000%), 5/31/2030	2,010,333
949,102		Gardner Denver, Inc., 2020 USD Term Loan B2–1st Lien, 7.206% (SOFR CME +1.750%), 3/1/2027	950,486
1,319,171		Gates Global, LLC, 2021 Term Loan B3–1st Lien, 7.956% (SOFR CME +2.500%), 3/31/2027	1,319,543
1,280,778		Gates Global, LLC, 2022 Term Loan B4–1st Lien, 8.356% (SOFR CME +3.000%), 11/16/2029	1,283,140
1,867,342		Watlow Electric Manufacturing Co., Term Loan B–1st Lien, 9.402% (SOFR CME +3.750%), 3/2/2028	1,870,843
		TOTAL	7,434,345
		Finance Companies—0.6%
2,750,000	2	GTCR W. Merger Sub, LLC, USD Term Loan B–1st Lien, TBD, 9/20/2030	2,765,469
		Food & Beverage—0.7%
1,365,000		Aramark Services, Inc., 2019 Term Loan B4–1st Lien, 7.220% (SOFR CME +1.750%), 1/15/2027	1,365,423
935,341		City Brewing Co., LLC, Closing Date Term Loan–1st Lien, 9.164% (SOFR CME +3.500%), 4/5/2028	741,699
992,864		US Foods, Inc., 2021 Term Loan B–1st Lien, 7.970% (SOFR CME +2.500%), 11/22/2028	998,563
		TOTAL	3,105,685
		Gaming—4.4%
1,940,250		Caesars Entertainment Corp., Term Loan B–1st Lien, 8.706% (SOFR CME +3.250%), 2/6/2030	1,943,087
2,385,816		Century Casinos, Inc., 2022 Term Loan–1st Lien, 11.443% (SOFR CME +6.000%), 4/2/2029	2,320,862
1,995,000		Golden Entertainment, Inc., 2023 Term Loan B–1st Lien, 8.206% (SOFR CME +2.750%), 5/28/2030	1,992,288
3,204,388		Great Canadian Gaming Corp., 2021 Term Loan–1st Lien, 9.633% (SOFR CME +4.000%), 11/1/2026	3,212,592
1,534,771		J&J Ventures Gaming, LLC, Term Loan–1st Lien, 9.610% (SOFR CME +4.000%), 4/26/2028	1,523,064
1,937,771		Jack Ohio Finance, LLC, Term Loan–1st Lien, 10.220% (SOFR CME +4.750%), 10/4/2028	1,910,180
1,900,000		Ontario Gaming GTA, LP, Term Loan B–1st Lien, 9.598% (SOFR CME +4.250%), 8/1/2030	1,910,517
2,472,519		Scientific Games Holdings, LP, 2022 USD Term Loan B–1st Lien, 8.664% (SOFR CME +3.250%), 4/4/2029	2,470,283
1,975,000		Scientific Games International, Inc., 2022 USD Term Loan–1st Lien, 8.465% (SOFR CME +3.000%), 4/14/2029	1,978,619
		TOTAL	19,261,492
		Health Care—7.4%
1,000,000		AHP Health Partners, Inc., 2021 Term Loan B–1st Lien, 8.970% (SOFR CME +3.500%), 8/24/2028	1,002,282
3,887,257		Athenahealth Group, Inc., 2022 Term Loan B–1st Lien, 8.606% (SOFR CME +3.250%), 2/15/2029	3,865,783
966,541		Avantor Funding, Inc., 2021 Term Loan B5–1st Lien, 7.706% (SOFR CME +2.250%), 11/8/2027	963,571
5,000,000	3	Carestream Dental Equipment, Inc., 2021 2nd Lien Term Loan–2nd Lien, 13.448% (SOFR CME +8.000%), 9/1/2025	1,250,000

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—continued
		Health Care—continued
$ 1,097,784		Carestream Health, Inc., 2022 Term Loan–1st Lien, 12.948% (SOFR CME +7.500%), 9/30/2027	$ 857,990
2,396,008		Curium BidCo S.a r.l., 2023 USD Term Loan B–1st Lien, 9.848% (SOFR CME +4.500%), 7/31/2029	2,391,509
5,000,000		Exactech, Inc., 2018 Term Loan B–1st Lien, 9.238% (SOFR CME +3.750%), 2/14/2025	2,649,088
895,250		Fortrea Holdings, Inc., Term Loan B–1st Lien, 9.106% (SOFR CME +3.750%), 7/1/2030	893,377
1,850,000		Grifols Worldwide Operations USA, Inc., USD 2019 Term Loan B–1st Lien, 7.538% (SOFR CME +2.000%), 11/15/2027	1,847,501
2,000,000		IQVIA, Inc., 2023 USD Term Loan B4–1st Lien, 7.348% (SOFR CME +2.000%), 1/2/2031	2,010,540
1,000,000		MDVIP, Inc., 2021 Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 10/16/2028	998,190
3,935,163		Medline Borrower, LP, USD Term Loan B–1st Lien, 8.470% (SOFR CME +3.000%), 10/23/2028	3,949,394
2,000,000		MH Sub I, LLC, 2021 2nd Lien Term Loan–2nd Lien, 11.606% (SOFR CME +6.250%), 2/23/2029	1,878,210
2,500,000		MH Sub I, LLC, 2023 Term Loan–1st Lien, 9.606% (SOFR CME +4.250%), 5/3/2028	2,456,328
1,958,119		National Mentor Holdings, Inc., 2021 Term Loan–1st Lien, 9.198%–9.206% (SOFR CME +3.750%), 3/2/2028	1,784,234
15,419		National Mentor Holdings, Inc., 2021 Term Loan C–1st Lien, 9.198% (SOFR CME +3.750%), 3/2/2028	14,086
1,927,195		Navicure, Inc., 2019 Term Loan B–1st Lien, 9.470% (SOFR CME +4.000%), 10/22/2026	1,931,813
2,095,707		Parexel International Corp., 2021 1st Lien Term Loan–1st Lien, 8.720% (SOFR CME +3.250%), 11/15/2028	2,105,282
		TOTAL	32,849,178
		Industrial - Other—3.7%
1,487,488		FCG Acquisitions, Inc., 2022 Incremental Term Loan–1st Lien, 10.106% (SOFR CME +4.750%), 3/31/2028	1,483,887
937,894		Filtration Group Corp., 2021 Incremental Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 10/21/2028	937,841
2,233,241		Filtration Group Corp., 2023 USD Term Loan–1st Lien, 9.720% (SOFR CME +4.250%), 10/21/2028	2,240,160
1,500,000		Fluid-Flow Products, Inc., Second Lien Term Loan–2nd Lien, 12.220% (SOFR CME +6.750%), 3/30/2029	1,426,177
3,112,797		Madison IAQ, LLC, Term Loan–1st Lien, 8.721% (SOFR CME +3.250%), 6/21/2028	3,099,543
1,034,530		Resideo Funding, Inc., 2021 Term Loan–1st Lien, 7.719%–7.729% (SOFR CME +2.250%), 2/11/2028	1,034,457
1,985,025		Roper Industrial Products Investment Co., LLC, 2023 USD Term Loan–1st Lien, 9.360% (SOFR CME +4.000%), 11/22/2029	1,991,853
2,212,804		SPX Flow, Inc., 2022 Term Loan–1st Lien, 9.956% (SOFR CME +4.500%), 4/5/2029	2,222,950
1,857,447		Vertical US Newco, Inc., Term Loan B–1st Lien, 9.381% (SOFR CME +3.500%), 7/30/2027	1,859,288
		TOTAL	16,296,156
		Insurance - P&C—7.9%
1,782,324		AmWINS Group, Inc., 2021 Term Loan B–1st Lien, 7.720% (SOFR CME +2.250%), 2/19/2028	1,782,749
992,500		AmWINS Group, Inc., 2023 Incremental Term Loan B–1st Lien, 8.220% (SOFR CME +2.750%), 2/19/2028	994,024
1,621,097		AssuredPartners, Inc., 2020 Term Loan B–1st Lien, 8.970% (SOFR CME +3.500%), 2/12/2027	1,622,554
1,873,911		AssuredPartners, Inc., 2021 Term Loan B–1st Lien, 8.970% (SOFR CME +3.500%), 2/12/2027	1,876,128
987,519		AssuredPartners, Inc., 2023 Term Loan B4–1st Lien, 9.220% (SOFR CME +3.750%), 2/12/2027	990,153
1,015,991		Asurion, LLC, 2020 Term Loan B8–1st Lien, 8.720% (SOFR CME +3.250%), 12/23/2026	1,012,817
1,000,000		Asurion, LLC, 2021 Second Lien Term Loan B4–2nd Lien, 10.720% (SOFR CME +5.250%), 1/20/2029	946,170
937,937		Asurion, LLC, 2021 Term Loan B9–1st Lien, 8.720% (SOFR CME +3.250%), 7/31/2027	930,049
3,244,375		Broadstreet Partners, Inc., 2023 1st Lien Term Loan B3–1st Lien, 9.116% (SOFR CME +3.750%), 1/27/2029	3,258,228
2,000,000		Homeserve USA Holding Corp., Term Loan–1st Lien, 8.358% (SOFR CME +3.000%), 10/21/2030	2,008,750
2,138,256		HUB International Ltd., 2022 Term Loan B–1st Lien, 9.369% (SOFR CME +4.000%), 11/10/2029	2,143,535
2,000,000		HUB International Ltd., 2023 Term Loan B–1st Lien, 9.662% (SOFR CME +4.250%), 6/20/2030	2,006,082
2,400,000		Jones DesLauriers Insurance Management, Inc., 2023 Term Loan B–1st Lien, 9.624% (SOFR CME +4.250%), 3/15/2030	2,413,500
2,791,799		NFP Corp., 2020 Term Loan–1st Lien, 8.720% (SOFR CME +3.250%), 2/16/2027	2,802,193
1,393,225		Ryan Specialty Group, LLC, Term Loan–1st Lien, 8.456% (SOFR CME +3.000%), 9/1/2027	1,390,795
3,513,251		Sedgwick Claims Management Services, Inc., 2023 Term Loan B–1st Lien, 9.106% (SOFR CME +3.750%), 2/24/2028	3,519,510
2,201,110		USI, Inc., 2022 Incremental Term Loan–1st Lien, 8.360% (SOFR CME +3.000%), 11/22/2029	2,208,164
3,193,107		USI, Inc., 2023 Acquisition Term Loan–1st Lien, 8.598% (SOFR CME +3.250%), 9/27/2030	3,202,947
		TOTAL	35,108,348
		Leisure—1.2%
1,314,088		Alterra Mountain Co., 2023 Term Loan B–1st Lien, 9.206% (SOFR CME +3.750%), 5/31/2030	1,320,625
1,895,250		Carnival Corp., 2023 Term Loan B–1st Lien, 8.357% (SOFR CME +3.000%), 8/8/2027	1,897,590

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—continued
		Leisure—continued
$ 2,100,000		Delta 2 (LUX) S.a.r.l., 2022 Term Loan B–1st Lien, 7.598% (SOFR CME +2.250%), 1/15/2030	$ 2,108,211
		TOTAL	5,326,426
		Lodging—0.7%
1,836,125		Four Seasons Hotels Ltd., 2023 Term Loan B–1st Lien, 7.956% (SOFR CME +2.500%), 11/30/2029	1,840,886
997,500		Wyndham Hotels & Resorts, Inc., 2023 Term Loan B–1st Lien, 7.706% (SOFR CME +2.250%), 5/24/2030	998,796
		TOTAL	2,839,682
		Media Entertainment—4.9%
2,098,429		Aragorn Parent Corp., Term Loan–1st Lien, 9.612% (SOFR CME +4.250%), 6/15/2028	2,099,090
380		AVSC Holding Corp., 2020 Term Loan B1–1st Lien, 9.206% (8.956% Cash SOFR CME +3.250%, 0.250% PIK), 3/3/2025	374
1,489,141		AVSC Holding Corp., 2020 Term Loan B2–1st Lien, 11.956% (10.956% Cash SOFR CME +5.500%, 1.000% PIK), 10/15/2026	1,462,463
2,159,743		Comet Bidco Ltd., 2018 USD Term Loan B–1st Lien, 11.408% (10.158% Cash SOFR CME +5.000%, 1.250% PIK), 9/30/2027	2,084,737
2,598,976		Emerald Expositions Holding, Inc., 2017 Term Loan B–1st Lien, 10.456% (SOFR CME +5.000%), 5/22/2026	2,611,258
1,957,613		Gray Television, Inc., 2021 Term Loan D–1st Lien, 8.457% (SOFR CME +3.000%), 12/1/2028	1,942,107
1,712,612		iHeartCommunications, Inc., 2020 Incremental Term Loan–1st Lien, 8.720% (SOFR CME +3.250%), 5/1/2026	1,476,956
1,894,454		Magnite, Inc., Term Loan–1st Lien, 10.470%–10.650% (SOFR CME +5.000%), 4/28/2028	1,898,669
1,860,439		NEP Group, Inc., Incremental Term Loan B–1st Lien, 9.378% (SOFR CME +4.000%), 8/19/2026	1,781,370
1,528,190		Nexstar Broadcasting, Inc., 2019 Term Loan B4–1st Lien, 7.970% (SOFR CME +2.500%), 9/18/2026	1,530,819
526,866		Outfront Media Capital, LLC, 2019 Term Loan B–1st Lien, 7.106% (SOFR CME +1.750%), 11/18/2026	526,096
1,478,775		Sinclair Television Group, Inc., 2022 Term Loan B4–1st Lien, 9.206% (SOFR CME +3.750%), 4/21/2029	1,211,738
1,876,250		Univision Communications, Inc., 2022 First Lien Term Loan B–1st Lien, 9.598% (SOFR CME +4.250%), 6/24/2029	1,878,986
960,088		Univision Communications, Inc., 2022 Term Loan B–1st Lien, 8.720% (SOFR CME +3.250%), 1/31/2029	957,948
		TOTAL	21,462,611
		Metals & Mining—0.3%
1,460,101		Grinding Media, Inc., 2021 Term Loan B–1st Lien, 9.684% (SOFR CME +4.000%), 10/12/2028	1,456,376
		Oil Field Services—0.3%
1,362,194		ChampionX Corp., 2022 Term Loan B2–1st Lien, 8.206% (SOFR CME +2.750%), 6/7/2029	1,365,800
		Packaging—4.3%
3,917		Anchor Glass Container Corp., 2023 PIK Term Loan–2nd Lien, 14.827% (SOFR CME +9.000%), 6/7/2026	1,685
3,000,000		Berry Global, Inc., 2023 Term Loan AA–1st Lien, 7.222% (SOFR CME +1.750%), 7/1/2029	2,999,667
4,299,597		Charter NEX US, Inc., 2021 Term Loan–1st Lien, 9.220% (SOFR CME +3.750%), 12/1/2027	4,324,471
3,621,722		Clydesdale Acquisition Holdings, Inc., Term Loan B–1st Lien, 9.631% (SOFR CME +4.175%), 4/13/2029	3,632,873
1,990,000		Mauser Packaging Solutions Holding Co., Term Loan B–1st Lien, 9.343% (SOFR CME +4.000%), 8/14/2026	2,000,089
1,000,000		Proampac PG Borrower, LLC, 2023 Term Loan–1st Lien, 9.868%–9.887% (SOFR CME +4.500%), 9/15/2028	1,003,125
4,000,000		RLG Holdings, LLC, 2021 2nd Lien Term Loan–2nd Lien, 12.970% (SOFR CME +7.500%), 7/6/2029	3,606,660
1,433,134		Trident TPI Holdings, Inc., 2021 Term Loan B3–1st Lien, 9.610% (SOFR CME +4.000%), 9/15/2028	1,427,444
		TOTAL	18,996,014
		Pharmaceuticals—1.2%
1,820,676		ICON Luxembourg S.a.r.l., LUX Term Loan–1st Lien, 7.860% (SOFR CME +2.250%), 7/3/2028	1,698,865
1,617,887		Jazz Financing Lux S.a.r.l., USD Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 5/5/2028	1,623,708
1,506,056		Organon & Co., USD Term Loan–1st Lien, 8.472% (SOFR CME +3.000%), 6/2/2028	1,511,711
453,623		PRA Health Sciences, Inc., US Term Loan–1st Lien, 7.860% (SOFR CME +2.250%), 7/3/2028	423,273
		TOTAL	5,257,557
		Restaurant—0.9%
2,500,000		1011778 B.C. Unlimited Liability Co., 2023 Term Loan B5–1st Lien, 7.606% (SOFR CME +2.250%), 9/20/2030	2,504,012
1,623,383		IRB Holding Corp., 2022 Term Loan B–1st Lien, 8.456% (SOFR CME +3.000%), 12/15/2027	1,623,886
		TOTAL	4,127,898
		Retailers—0.8%
1,471,332		ABG Intermediate Holdings 2, LLC, 2021 Term Loan B1–1st Lien, 8.850% (SOFR CME +3.500%), 12/21/2028	1,476,265
1,312,642		Petco Health and Wellness Co., Inc., 2021 Term Loan B–1st Lien, 8.860% (SOFR CME +3.250%), 3/3/2028	1,244,549

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—continued
		Retailers—continued
$ 995,000		Sally Holdings, LLC, 2023 CovLite Term Loan B–1st Lien, 7.606% (SOFR CME +2.250%), 2/28/2030	$ 998,237
		TOTAL	3,719,051
		Services—1.4%
1,863,125		Covetrus, Inc., Term Loan–1st Lien, 10.348% (SOFR CME +5.000%), 10/13/2029	1,859,903
2,167,223		Service Logic Acquisition, Inc, Term Loan–1st Lien, 9.645% (SOFR CME +4.000%), 10/29/2027	2,163,461
1,000,000		USIC Holdings, Inc., 2021 2nd Lien Term Loan–2nd Lien, 12.110% (SOFR CME +6.500%), 5/14/2029	930,625
1,207,792		USIC Holdings, Inc., 2021 Term Loan–1st Lien, 9.110% (SOFR CME +3.500%), 5/12/2028	1,197,482
		TOTAL	6,151,471
		Technology—22.2%
1,500,000		Altar Bidco, Inc., 2021 2nd Lien Term Loan–2nd Lien, 10.813% (SOFR CME +5.600%), 2/1/2030	1,488,750
1,963,825		Altar Bidco, Inc., 2021 Term Loan–1st Lien, 8.262%–8.313% (SOFR CME +3.100%), 2/1/2029	1,959,059
2,139,438		Applied Systems, Inc., 2022 Extended 1st Lien Term Loan–1st Lien, 9.848% (SOFR CME +4.500%), 9/18/2026	2,146,430
1,204,559		AppLovin Corp., 2021 Term Loan B–1st Lien, 8.556% (SOFR CME +3.100%), 10/25/2028	1,203,832
920,250		AppLovin Corp., 2023 Term Loan B–1st Lien, 8.456% (SOFR CME +3.100%), 8/16/2030	919,793
1,000,000		Atlas Purchaser, Inc., 2021 2nd Lien Term Loan–2nd Lien, 14.642% (SOFR CME +9.000%), 5/7/2029	358,330
1,917,880		Atlas Purchaser, Inc., 2021 Term Loan–1st Lien, 10.877% (SOFR CME +5.250%), 5/8/2028	1,142,209
1,000,000		Banff Merger Sub, Inc., 2021 USD 2nd Lien Term Loan–2nd Lien, 10.970% (SOFR CME +5.500%), 2/27/2026	1,000,000
500,000		Banff Merger Sub, Inc., 2021 USD Term Loan–1st Lien, 9.606% (SOFR CME +3.750%), 10/2/2025	504,313
1,219,244		Banff Merger Sub, Inc., 2023 USD Term Loan–1st Lien, 9.606% (SOFR CME +4.250%), 12/29/2028	1,224,963
1,500,000		Barracuda Networks, Inc., 2022 2nd Lien Term Loan–2nd Lien, 12.383% (SOFR CME +7.000%), 8/15/2030	1,340,940
1,972,519		Barracuda Networks, Inc., 2022 Term Loan–1st Lien, 9.883% (SOFR CME +4.500%), 8/15/2029	1,931,224
1,965,000		CCC Intelligent Solutions, Inc., Term Loan–1st Lien, 7.720% (SOFR CME +2.250%), 9/21/2028	1,963,273
2,586,125		Central Parent, Inc., 2023 Term Loan B–1st Lien, 9.348% (SOFR CME +4.000%), 7/6/2029	2,603,762
3,830,342		Cloud Software Group, Inc., 2022 USD Term Loan B–1st Lien, 9.948% (SOFR CME +4.500%), 3/30/2029	3,751,111
1,000,000		Cloudera, Inc., 2021 Second Lien Term Loan–2nd Lien, 11.456% (SOFR CME +6.000%), 10/8/2029	963,330
2,195,782		Cloudera, Inc., 2021 Term Loan–1st Lien, 9.206% (SOFR CME +3.750%), 10/8/2028	2,180,686
1,441,587		CoreLogic, Inc., Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 6/2/2028	1,403,163
2,250,000		Cvent, Inc., 2023 Term Loan B–1st Lien, 9.098% (SOFR CME +3.750%), 6/17/2030	2,251,287
1,944,584		DCert Buyer, Inc., 2019 Term Loan B–1st Lien, 9.356% (SOFR CME +4.000%), 10/16/2026	1,926,435
1,000,000		DCert Buyer, Inc., 2021 2nd Lien Term Loan–2nd Lien, 12.356% (SOFR CME +7.000%), 2/19/2029	915,000
1,395,532		Diebold Nixdorf, Inc., 2023 Exit Term Loan–1st Lien, 12.860% (SOFR CME +7.500%), 8/11/2028	1,438,703
2,381,787		Epicor Software Corp., 2020 Term Loan–1st Lien, 8.720% (SOFR CME +3.250%), 7/30/2027	2,386,897
2,188,414		Gainwell Acquisition Corp., Term Loan B–1st Lien, 9.448% (SOFR CME +4.000%), 10/1/2027	2,128,219
915,802		Go Daddy Operating Co., LLC, 2021 Term Loan B4–1st Lien, 7.470% (SOFR CME +2.000%), 8/10/2027	916,290
992,512		Go Daddy Operating Co., LLC, 2022 Term Loan B5–1st Lien, 7.856% (SOFR CME +2.500%), 11/9/2029	994,535
2,312,879		GoTo Group, Inc., Term Loan B–1st Lien, 10.283% (SOFR CME +4.750%), 8/31/2027	1,537,410
2,432,644		Greeneden U.S. Holdings II, LLC, 2020 USD Term Loan B4–1st Lien, 9.470% (SOFR CME +4.000%), 12/1/2027	2,445,014
1,314,083		II-VI, Inc., 2022 Term Loan B–1st Lien, 8.220% (SOFR CME +2.750%), 7/2/2029	1,296,922
1,500,000	2	Iron Mountain, Inc., 2023 Term Loan B–1st Lien, TBD, 1/31/2031	1,502,347
1,875,000		Marcel LUX IV S.a.r.l., 2023 USD Term Loan B–1st Lien, 9.835% (SOFR CME +4.500%), 11/11/2030	1,887,506
3,000,000		McAfee, LLC, 2022 USD Term Loan B–1st Lien, 9.193% (SOFR CME +3.750%), 3/1/2029	2,988,051
1,000,000		Mitchell International, Inc., 2021 2nd Lien Term Loan–2nd Lien, 12.150% (SOFR CME +6.500%), 10/15/2029	984,690
1,719,227		Mitchell International, Inc., 2021 Term Loan B–1st Lien, 9.400% (SOFR CME +3.750%), 10/15/2028	1,716,595
4,785,223		MLN US HoldCo, LLC, 2018 1st Lien Term Loan–1st Lien, 9.972% (SOFR CME +4.500%), 11/30/2025	558,268
1,750,000		NCR Atleos, LLC, Term Loan B–1st Lien, 10.206% (SOFR CME +4.750%), 3/27/2029	1,746,719
1,500,000		NEXUS Buyer, LLC, 2021 Second Lien Term Loan–2nd Lien, 11.706% (SOFR CME +6.250%), 11/5/2029	1,469,062
2,296,151		NEXUS Buyer, LLC, Term Loan B–1st Lien, 9.206% (SOFR CME +3.750%), 11/9/2026	2,271,717
1,603,106		Open Text Corp., 2023 Term Loan B–1st Lien, 8.206% (SOFR CME +2.750%), 1/31/2030	1,604,586
2,272,652		Optiv Security, Inc., 2023 Term Loan–1st Lien, 10.630% (SOFR CME +5.250%), 7/31/2026	2,172,891
2,703,390		Planview Parent, Inc., Term Loan–1st Lien, 9.610% (SOFR CME +4.000%), 12/17/2027	2,679,413

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
	1	FLOATING RATE LOANS—continued
		Technology—continued
$ 1,500,000		Project Alpha Intermediate Holding, Inc., 2023 1st Lien Term Loan B–1st Lien, 10.106% (SOFR CME +4.750%), 10/28/2030	$ 1,511,092
1,453,877		Project Boost Purchaser, LLC, 2021 Incremental Term Loan–1st Lien, 8.970% (SOFR CME +3.500%), 5/30/2026	1,453,182
1,900,000		Quartz Acquireco, LLC, Term Loan B–1st Lien, 8.856% (SOFR CME +3.500%), 6/28/2030	1,903,542
2,000,000		Renaissance Holding Corp., 2023 Refi Term Loan–1st Lien, 10.106% (SOFR CME +4.750%), 4/5/2030	2,004,696
1,813,720		Rocket Software, Inc., 2023 USD Term Loan B–1st Lien, 10.106% (SOFR CME +4.750%), 11/28/2028	1,780,917
1,885,175		S2P Acquisition Borrower, Inc., Term Loan–1st Lien, 9.456% (SOFR CME +4.000%), 8/14/2026	1,886,649
2,156,309		Severin Acquisition, LLC, 2018 Term Loan B–1st Lien, 8.633% (SOFR CME +3.250%), 8/1/2027	2,167,770
1,458,975		Sophia, LP, 2021 Term Loan B–1st Lien, 8.956% (SOFR CME +3.500%), 10/7/2027	1,460,143
1,476,288		Sophia, LP, 2022 Incremental Term Loan B–1st Lien, 9.606% (SOFR CME +4.250%), 10/7/2027	1,475,311
898,922		SS&C Technologies, Inc., 2022 Term Loan B6–1st Lien, 7.706% (SOFR CME +2.250%), 3/22/2029	901,470
1,019,774		SS&C Technologies, Inc., 2022 Term Loan B7–1st Lien, 7.706% (SOFR CME +2.250%), 3/22/2029	1,022,665
1,332,814		Tempo Acquisition, LLC, 2023 Term Loan B–1st Lien, 8.106% (SOFR CME +2.750%), 8/31/2028	1,337,191
162,842		Trans Union, LLC, 2021 Term Loan B6–1st Lien, 7.720% (SOFR CME +2.250%), 12/1/2028	160,796
1,900,000		Ultimate Software Group, Inc. (The), 2021 2nd Lien Term Loan–2nd Lien, 10.764% (SOFR CME +5.250%), 5/3/2027	1,907,296
1,888,045		Ultimate Software Group, Inc. (The), Term Loan B–1st Lien, 9.233% (SOFR CME +3.750%), 5/4/2026	1,889,946
2,000,000		Vertiv Group Corp., 2023 Term Loan B–1st Lien, 7.974% (SOFR CME +2.500%), 3/2/2027	2,009,130
2,168,705		VS Buyer, LLC, Term Loan B–1st Lien, 8.706% (SOFR CME +3.250%), 2/28/2027	2,171,198
1,921,340		Weld North Education, LLC, 2021 Term Loan B–1st Lien, 9.220% (SOFR CME +3.750%), 12/21/2027	1,918,997
1,492,500		World Wide Technology Holding Co., LLC, Term Loan–1st Lien, 8.707% (SOFR CME +3.250%), 3/1/2030	1,496,201
		TOTAL	98,361,917
		Transportation Services—0.4%
1,877,962		Genesee & Wyoming, Inc. (New), Term Loan–1st Lien, 7.448% (SOFR CME +2.000%), 12/30/2026	1,879,671
		Utility - Electric—1.1%
1,506,759		Calpine Construction Finance Co., LP, 2023 Refinancing Term Loan B–1st Lien, 7.606% (SOFR CME +2.250%), 7/31/2030	1,505,059
653,846		Calpine Corp., 2020 Term Loan B5–1st Lien, 7.970% (SOFR CME +2.500%), 12/16/2027	655,916
2,500,000	2	Vistra Operations Co., LLC, 2023 Fungible Term Loan–1st Lien, TBD, 12/6/2030	2,503,237
		TOTAL	4,664,212
		Wireless Communications—0.4%
1,651,136		Iridium Satellite, LLC, 2023 Term Loan B–1st Lien, 7.856% (SOFR CME +2.500%), 9/20/2030	1,657,791
		TOTAL FLOATING RATE LOANS (IDENTIFIED COST $392,265,582)	381,759,774
		CORPORATE BONDS—5.7%
		Airlines—0.3%
833,333		American Airlines, Inc./AAdvantage Loyalty IP Ltd., 144A, 5.500%, 4/20/2026	827,935
350,000		Mileage Plus Holdings LLC, 144A, 6.500%, 6/20/2027	351,249
		TOTAL	1,179,184
		Automotive—0.4%
700,000		Clarios Global LP, Sec. Fac. Bond, 144A, 6.750%, 5/15/2028	714,588
1,000,000		Panther BF Aggregator 2 LP, Sr. Unsecd. Note, 144A, 8.500%, 5/15/2027	1,005,361
		TOTAL	1,719,949
		Banking—0.1%
350,000		Ally Financial, Inc., Sr. Sub. Note, 5.750%, 11/20/2025	348,087
		Cable Satellite—0.5%
1,000,000		DISH Network Corp., Sec. Fac. Bond, 144A, 11.750%, 11/15/2027	1,044,672
1,125,000		Ziggo Finance B.V., Sr. Unsecd. Note, 144A, 6.000%, 1/15/2027	1,095,966
		TOTAL	2,140,638
		Consumer Cyclical Services—0.1%
500,000		Garda World Security Corp., Sec. Fac. Bond, 144A, 7.750%, 2/15/2028	517,815
		Consumer Products—0.2%
700,000		BCPE Empire Holdings, Inc., Sr. Unsecd. Note, 144A, 7.625%, 5/1/2027	675,711

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
		CORPORATE BONDS—continued
		Diversified Manufacturing—0.2%
$ 1,075,000		WESCO Distribution, Inc., Sr. Unsecd. Note, 144A, 7.125%, 6/15/2025	$ 1,083,645
		Finance Companies—0.2%
800,000	1	American Express Co., Sr. Unsecd. Note, 6.156% (SOFR +0.760%), 2/13/2026	798,577
250,000	1	American Express Co., Sr. Unsecd. Note, 6.344% (SOFR +0.930%), 3/4/2025	250,628
		TOTAL	1,049,205
		Financial Institutions—0.1%
500,000		Manufacturers & Traders Trust Co., Sr. Unsecd. Note, 4.650%, 1/27/2026	489,801
		Gaming—0.6%
1,000,000		Affinity Gaming LLC, 144A, 6.875%, 12/15/2027	892,154
900,000		Churchill Downs, Inc., Sr. Unsecd. Note, 144A, 5.500%, 4/1/2027	891,247
1,000,000		Scientific Games International, Inc., Sr. Unsecd. Note, 144A, 7.000%, 5/15/2028	1,010,976
		TOTAL	2,794,377
		Health Care—0.3%
1,350,000		Ardent Health Services, Sr. Unsecd. Note, 144A, 5.750%, 7/15/2029	1,181,511
		Independent Energy—0.3%
1,350,000		Crownrock LP/Crownrock F, Sr. Unsecd. Note, 144A, 5.625%, 10/15/2025	1,349,048
		Insurance - P&C—0.2%
750,000		Hub International Ltd., Sr. Unsecd. Note, 144A, 7.000%, 5/1/2026	753,769
		Lodging—0.1%
300,000		RHP Hotel Property/RHP Finance Corp., Sr. Unsecd. Note, 144A, 7.250%, 7/15/2028	312,093
		Media Entertainment—0.2%
1,000,000		iHeartCommunications, Inc., 6.375%, 5/1/2026	853,543
		Midstream—0.1%
500,000		EQM Midstream Partners, LP, Sr. Unsecd. Note, 144A, 7.500%, 6/1/2027	515,511
		Packaging—0.5%
500,000		Ardagh Packaging Finance PLC/Ardagh Holdings, Sec. Fac. Bond, 144A, 5.250%, 4/30/2025	486,671
2,000,000		Ardagh Packaging Finance PLC/Ardagh Holdings, Sr. Unsecd. Note, 144A, 5.250%, 8/15/2027	1,556,079
		TOTAL	2,042,750
		Retailers—0.2%
1,100,000		Academy Ltd., Sec. Fac. Bond, 144A, 6.000%, 11/15/2027	1,081,511
		Technology—0.6%
1,000,000		Boxer Parent Co., Inc., 144A, 7.125%, 10/2/2025	1,006,430
1,775,000		Consensus Cloud Solutions, Inc., Sr. Unsecd. Note, 144A, 6.000%, 10/15/2026	1,689,463
		TOTAL	2,695,893
		Transportation Services—0.5%
2,200,000		Stena International S.A., Sec. Fac. Bond, 144A, 6.125%, 2/1/2025	2,192,899
		TOTAL CORPORATE BONDS (IDENTIFIED COST $25,165,004)	24,976,940
		ASSET-BACKED SECURITIES—2.1%
		Automotive—0.7%
259,587		BMW Vehicle Lease Trust 2023-1, Class A2, 5.270%, 2/25/2025	259,411
441,924	1	Chesapeake Funding II LLC 2023-1A, Class A2, 6.588% (30-DAY AVERAGE SOFR +1.250%), 5/15/2035	442,086
348,331		Enterprise Fleet Financing LLC 2022-4, Class A2, 5.760%, 10/22/2029	349,460
274,971		Enterprise Fleet Financing LLC 2023-1, Class A2, 5.510%, 1/22/2029	275,302
593,588		GM Financial Securitized Term 2023-1, Class A2A, 5.190%, 3/16/2026	592,356
120,306	1	Toyota Auto Receivables Owner 2022-D, Class A2B, 6.051% (CME Term SOFR 1 Month +0.690%), 1/15/2026	120,420
623,787		Toyota Auto Receivables Owner Trust 2023-A, Class A2, 5.050%, 1/15/2026	622,661
500,000		Volkswagen Auto Lease Trust 2022-A, Class A3, 3.440%, 7/21/2025	496,120
		TOTAL	3,157,816

Semi-Annual Shareholder Report

Principal Amount or Shares			Value
		ASSET-BACKED SECURITIES—continued
		Credit Card—0.5%
$ 750,000		Evergreen Credit Card Trust 2022-CRT2 C, Class C, 7.440%, 11/16/2026	$ 751,606
850,000		Evergreen Credit Card Trust 2022-CRT2, Class B, 6.560%, 11/16/2026	852,271
600,000		Evergreen Credit Card Trust Series 2023-CRT3, Class B, 6.580%, 2/16/2027	603,412
		TOTAL	2,207,289
		Equipment Lease—0.1%
563,540		DLLAD LLC 2023-1A, Class A2, 5.190%, 4/20/2026	561,669
		Other—0.8%
500,000	1	Elmwood CLO 23 Ltd. 2023-2A, Class A, 7.193% (CME Term SOFR 3 Month +1.800%), 4/16/2036	501,915
500,000	1	Elmwood CLO 23 Ltd. 2023-2A, Class B, 7.643% (CME Term SOFR 3 Month +2.250%), 4/16/2036	500,603
750,000	1	GoldenTree Loan Management US 2020-7A, Class CR, 7.727% (CME Term SOFR 3 Month +2.311%), 4/20/2034	749,998
750,000	1	GoldenTree Loan Management US 2023-17A, Class A, 6.997% (CME Term SOFR 3 Month +1.750%), 7/20/2036	753,195
500,000	1	GoldenTree Loan Management US 2023-17A, Class B, 7.697% (CME Term SOFR 3 Month +2.450%), 7/20/2036	503,109
344,745		MMAF Equipment Finance LLC 2022-B, Class A2, 5.570%, 9/9/2025	344,222
		TOTAL	3,353,042
		TOTAL ASSET-BACKED SECURITIES (IDENTIFIED COST $9,270,441)	9,279,816
		COMMON STOCKS—0.0%
		Aerospace/Defense—0.0%
46,202	4	Constellis Holdings LLC	13,283
		Health Care—0.0%
180,104	4	Carestream Health, Inc.	54,031
		TOTAL COMMON STOCKS (IDENTIFIED COST $3,853,541)	67,314
		EXCHANGE-TRADED FUNDS—1.4%
200,000		Invesco Senior Loan ETF	4,236,000
50,000		SPDR Blackstone Senior Loan ETF	2,096,500
		TOTAL EXCHANGE-TRADED FUNDS (IDENTIFIED COST $6,281,000)	6,332,500
		INVESTMENT COMPANY—4.9%
21,744,376		Federated Hermes Institutional Prime Value Obligations Fund, Institutional Shares, 5.45%5 (IDENTIFIED COST $21,745,420)	21,755,248
		TOTAL INVESTMENT IN SECURITIES—100.4% (IDENTIFIED COST $458,580,988)6	444,171,592
		OTHER ASSETS AND LIABILITIES - NET—(0.4)%7	(1,635,146)
		TOTAL NET ASSETS—100%	$442,536,446

Transactions with affiliated investment companies, which are funds managed by the Adviser or an affiliate of the Adviser, during the period ended December 31, 2023, were as follows:

	Federated Hermes Institutional Prime Value Obligations Fund, Institutional Shares
Value as of 6/30/2023	$7,715,875
Purchases at Cost	$117,684,832
Proceeds from Sales	$(103,659,643)
Change in Unrealized Appreciation/Depreciation	$10,247
Net Realized Gain/(Loss)	$3,937
Value as of 12/31/2023	$21,755,248
Shares Held as of 12/31/2023	21,744,376
Dividend Income	$452,663

Semi-Annual Shareholder Report

1	Floating/variable note with current rate and current maturity or next reset date shown.
2	All or a portion of the security represents unsettled loan commitments at December 31, 2023 where the rate will be determined at time of settlement.
3	Market quotations and price evaluations are not available. Fair value determined using significant unobservable inputs in accordance with procedures established by and under the general supervision of the Fund’s Adviser acting through its Valuation Committee (“Valuation Committee”).
4	Non-income-producing security.
5	7-day net yield.
6	The cost of investments for federal tax purposes amounts to $456,241,325.
7	Assets, other than investments in securities, less liabilities. See Statement of Assets and Liabilities.

Note: The categories of investments are shown as a percentage of total net assets at December 31, 2023.

Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:

Level 1—quoted prices in active markets for identical securities.

Level 2—other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). Also includes securities valued at amortized cost.

Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used, as of December 31, 2023, in valuing the Fund’s assets carried at fair value:

Valuation Inputs
	Level 1— Quoted Prices	Level 2— Other Significant Observable Inputs	Level 3— Significant Unobservable Inputs	Total
Debt Securities:
Floating Rate Loans	$—	$380,509,774	$1,250,000	$381,759,774
Corporate Bonds	—	24,976,940	—	24,976,940
Asset-Backed Securities	—	9,279,816	—	9,279,816
Exchange-Traded Funds	6,332,500	—	—	6,332,500
Equity Securities:
Common Stocks
Domestic	—	67,314	—	67,314
Investment Company	21,755,248	—	—	21,755,248
TOTAL SECURITIES	$28,087,748	$414,833,844	$1,250,000	$444,171,592

The following acronym(s) are used throughout this portfolio:
ETF	—Exchange-Traded Fund
PIK	—Payment in Kind
SOFR	—Secured Overnight Financing Rate
SPDR	—Standard & Poor’s Depositary Receipt
TBD	—To Be Determined
USD	—United States Dollar

See Notes which are an integral part of the Financial Statements

Semi-Annual Shareholder Report

Financial Highlights

(For a Share Outstanding Throughout Each Period)

	Six Months Ended (unaudited) 12/31/2023	Year Ended June 30,
	Six Months Ended (unaudited) 12/31/2023	2023	2022	2021	2020	2019
Net Asset Value, Beginning of Period	$8.67	$8.82	$9.69	$9.14	$9.83	$10.02
Income From Investment Operations:
Net investment income (loss)1	0.42	0.72	0.46	0.43	0.49	0.59
Net realized and unrealized gain (loss)	0.09	(0.15)	(0.86)	0.52	(0.69)	(0.20)
TOTAL FROM INVESTMENT OPERATIONS	0.51	0.57	(0.40)	0.95	(0.20)	0.39
Less Distributions:
Distributions from net investment income	(0.43)	(0.72)	(0.47)	(0.40)	(0.49)	(0.58)
Net Asset Value, End of Period	$8.75	$8.67	$8.82	$9.69	$9.14	$9.83
Total Return2	6.06%	6.68%	(4.39)%	10.50%	(2.15)%	4.02%
Ratios to Average Net Assets:
Net expenses3	0.10%4	0.06%	0.05%	0.05%	0.06%	0.06%
Net investment income	9.64%4	8.23%	4.83%	4.47%	5.22%	5.98%
Expense waiver/reimbursement5	—%	—%	—%	—%	—%	—%
Supplemental Data:
Net assets, end of period (000 omitted)	$442,536	$551,322	$1,354,326	$1,968,305	$1,148,240	$1,043,884
Portfolio turnover6	16%	22%	44%	31%	43%	38%

1	Per share numbers have been calculated using the average shares method.
2	Based on net asset value. Total returns for periods of less than one year are not annualized.
3	Amount does not reflect net expenses incurred by investment companies in which the Fund may invest.
4	Computed on an annualized basis.
5	This expense decrease is reflected in both the net expense and the net investment income ratios shown above. Amount does not reflect expense waiver/ reimbursement recorded by investment companies in which the Fund may invest.
6	Securities that mature are considered sales for purposes of this calculation.

See Notes which are an integral part of the Financial Statements

Semi-Annual Shareholder Report

Notes to Financial Statements

December 31, 2023 (unaudited)

1. ORGANIZATION

Federated Hermes Core Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “Act”), as an open-end management investment company. The Trust consists of four portfolios. The financial statements included herein are only those of Bank Loan Core Fund (the “Fund”), a diversified portfolio. The financial statements of the other portfolios are presented separately. The assets of each portfolio are segregated and a shareholder’s interest is limited to the portfolio in which shares are held. Each portfolio pays its own expenses. The Fund’s investment objective is to provide current income. Currently, shares of the Fund are being offered for investment only to investment companies, insurance company separate accounts, common or commingled trust funds or similar organizations or entities that are “accredited investors” within the meaning of Regulation D of the Securities Act of 1933, as amended (the “1933 Act”).

2. SIGNIFICANT ACCOUNTING POLICIES

The following is a summary of significant accounting policies consistently followed by the Fund in the preparation of its financial statements. These policies are in conformity with U.S. generally accepted accounting principles (GAAP).

Investment Valuation

In calculating its net asset value (NAV), the Fund generally values investments as follows:

■

Fixed-income securities and floating rate loans are fair valued using price evaluations provided by a pricing service approved by Federated Investment Management Company (the “Adviser”).

■

Shares of other mutual funds or non-exchange-traded investment companies are valued based upon their reported NAVs, or NAV per share practical expedient, as applicable.

■

Derivative contracts listed on exchanges are valued at their reported settlement or closing price, except that options are valued at the mean of closing bid and ask quotations.

■

Over-the-counter (OTC) derivative contracts are fair valued using price evaluations provided by a pricing service approved by the Adviser.

■

For securities that are fair valued in accordance with procedures established by and under the general supervision of the Adviser, certain factors may be considered, such as: the last traded or purchase price of the security, information obtained by contacting the issuer or dealers, analysis of the issuer’s financial statements or other available documents, fundamental analytical data, the nature and duration of restrictions on disposition, the movement of the market in which the security is normally traded, public trading in similar securities or derivative contracts of the issuer or comparable issuers, movement of a relevant index, or other factors including but not limited to industry changes and relevant government actions.

If any price, quotation, price evaluation or other pricing source is not readily available when the NAV is calculated, if the Fund cannot obtain price evaluations from a pricing service or from more than one dealer for an investment within a reasonable period of time as set forth in the Adviser’s valuation policies and procedures for the Fund, or if information furnished by a pricing service, in the opinion of the Adviser’s valuation committee (“Valuation Committee”), is deemed not representative of the fair value of such security, the Fund uses the fair value of the investment determined in accordance with the procedures described below. There can be no assurance that the Fund could obtain the fair value assigned to an investment if it sold the investment at approximately the time at which the Fund determines its NAV per share, and the actual value obtained could be materially different.

Fair Valuation and Significant Events Procedures

Pursuant to Rule 2a-5 under the Act, the Fund’s Board of Trustees (the “Trustees”) has designated the Adviser as the Fund’s valuation designee to perform any fair value determinations for securities and other assets held by the Fund. The Adviser is subject to the Trustees’ oversight and certain reporting and other requirements intended to provide the Trustees the information needed to oversee the Adviser’s fair value determinations.

The Adviser, acting through its Valuation Committee, is responsible for determining the fair value of investments for which market quotations are not readily available. The Valuation Committee is comprised of officers of the Adviser and certain of the Adviser’s affiliated companies and determines fair value and oversees the calculation of the NAV. The Valuation Committee is also authorized to use pricing services to provide fair value evaluations of the current value of certain investments for purposes of calculating the NAV. The Valuation Committee employs various methods for reviewing third-party pricing-service evaluations including periodic reviews of third-party pricing services’ policies, procedures and valuation methods (including key inputs, methods, models and assumptions), transactional back-testing, comparisons of evaluations of different pricing services, and review of price challenges by the Adviser based on recent market activity. In the event that market quotations and price evaluations are not available for an investment, the Valuation Committee determines the fair value of the investment in accordance with procedures adopted by the Adviser. The Trustees periodically review the fair valuations made by the Valuation Committee. The Trustees have also approved the Adviser’s fair valuation and significant events procedures as part of the Fund’s compliance program and will review any changes made to the procedures.

Factors considered by pricing services in evaluating an investment include the yields or prices of investments of comparable quality, coupon, maturity, call rights and other potential prepayments, terms and type, reported transactions, indications as to values from dealers and general market conditions. Some pricing services provide a single price evaluation reflecting the bid-side of the market for an investment (a “bid” evaluation). Other pricing services offer both bid evaluations and price evaluations indicative of a price between

Semi-Annual Shareholder Report

the prices bid and ask for the investment (a “mid” evaluation). The Fund normally uses bid evaluations for any U.S. Treasury and Agency securities, mortgage-backed securities and municipal securities. The Fund normally uses mid evaluations for any other types of fixed-income securities and any OTC derivative contracts. In the event that market quotations and price evaluations are not available for an investment, the fair value of the investment is determined in accordance with procedures adopted by the Adviser.

The Adviser has also adopted procedures requiring an investment to be priced at its fair value whenever the Valuation Committee determines that a significant event affecting the value of the investment has occurred between the time as of which the price of the investment would otherwise be determined and the time as of which the NAV is computed. An event is considered significant if there is both an affirmative expectation that the investment’s value will change in response to the event and a reasonable basis for quantifying the resulting change in value. Examples of significant events that may occur after the close of the principal market on which a security is traded, or after the time of a price evaluation provided by a pricing service or a dealer, include:

■

With respect to securities traded principally in foreign markets, significant trends in U.S. equity markets or in the trading of foreign securities index futures contracts;

■

Political or other developments affecting the economy or markets in which an issuer conducts its operations or its securities are traded;

■

Announcements concerning matters such as acquisitions, recapitalizations, litigation developments, or a natural disaster affecting the issuer’s operations or regulatory changes or market developments affecting the issuer’s industry.

The Adviser has adopted procedures whereby the Valuation Committee uses a pricing service to provide factors to update the fair value of equity securities traded principally in foreign markets from the time of the close of their respective foreign stock exchanges to the pricing time of the Fund. For other significant events, the Fund may seek to obtain more current quotations or price evaluations from alternative pricing sources. If a reliable alternative pricing source is not available, the Valuation Committee will determine the fair value of the investment in accordance with the fair valuation procedures approved by the Adviser. The Trustees periodically review fair valuations made in response to significant events.

Repurchase Agreements

The Fund may invest in repurchase agreements for short-term liquidity purposes. It is the policy of the Fund to require the other party to a repurchase agreement to transfer to the Fund’s custodian or sub-custodian eligible securities or cash with a market value (after transaction costs) at least equal to the repurchase price to be paid under the repurchase agreement. The eligible securities are transferred to accounts with the custodian or sub-custodian in which the Fund holds a “securities entitlement” and exercises “control” as those terms are defined in the Uniform Commercial Code. The Fund has established procedures for monitoring the market value of the transferred securities and requiring the transfer of additional eligible securities if necessary to equal at least the repurchase price. These procedures also allow the other party to require securities to be transferred from the account to the extent that their market value exceeds the repurchase price or in exchange for other eligible securities of equivalent market value.

The insolvency of the other party or other failure to repurchase the securities may delay the disposition of the underlying securities or cause the Fund to receive less than the full repurchase price. Under the terms of the repurchase agreement, any amounts received by the Fund in excess of the repurchase price and related transaction costs must be remitted to the other party.

The Fund may enter into repurchase agreements in which eligible securities are transferred into joint trading accounts maintained by the custodian or sub-custodian for investment companies and other clients advised by the Fund’s Adviser and its affiliates. The Fund will participate on a pro rata basis with the other investment companies and clients in its share of the securities transferred under such repurchase agreements and in its share of proceeds from any repurchase or other disposition of such securities.

Investment Income, Gains and Losses, Expenses and Distributions

Investment transactions are accounted for on a trade-date basis. Realized gains and losses from investment transactions are recorded on an identified-cost basis. Interest income and expenses are accrued daily. Dividend income and distributions to shareholders are recorded on the ex-dividend date. Foreign dividends are recorded on the ex-dividend date or when the Fund is informed of the ex-dividend date. Distributions of net investment income, if any, are declared daily and paid monthly. Non-cash dividends included in dividend income, if any, are recorded at fair value. Amortization/accretion of premium and discount is included in investment income.

Federal Taxes

It is the Fund’s policy to comply with the Subchapter M provision of the Internal Revenue Code of 1986 (the “Code”) and to distribute to shareholders each year substantially all of its income. Accordingly, no provision for federal income tax is necessary. As of and during the six months ended December 31, 2023, the Fund did not have a liability for any uncertain tax positions. The Fund recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statement of Operations. As of December 31, 2023, tax years 2020 through 2023 remain subject to examination by the Fund’s major tax jurisdictions, which include the United States of America and the Commonwealth of Massachusetts.

When-Issued and Delayed-Delivery Transactions

The Fund may engage in when-issued or delayed-delivery transactions. The Fund records when-issued securities on the trade date and maintains security positions such that sufficient liquid assets will be available to make payment for the securities purchased. Securities purchased on a when-issued or delayed-delivery basis are marked to market daily and begin earning interest on the settlement date. Losses may occur on these transactions due to changes in market conditions or the failure of counterparties to perform under the contract.

Semi-Annual Shareholder Report

Restricted Securities

The Fund may purchase securities which are considered restricted. Restricted securities are securities that either: (a) cannot be offered for public sale without first being registered, or being able to take advantage of an exemption from registration, under the 1933 Act; or (b) are subject to contractual restrictions on public sales. In some cases, when a security cannot be offered for public sale without first being registered, the issuer of the restricted security has agreed to register such securities for resale, at the issuer’s expense, either upon demand by the Fund or in connection with another registered offering of the securities. Many such restricted securities may be resold in the secondary market in transactions exempt from registration. Restricted securities may be determined to be liquid under criteria established by the Trustees. The Fund will not incur any registration costs upon such resales. The Fund’s restricted securities, like other securities, are priced in accordance with procedures established by and under the general supervision of the Adviser.

Foreign Currency Translation

The accounting records of the Fund are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rates of exchange of such currencies against U.S. dollars on the date of valuation. Purchases and sales of securities, income and expenses are translated at the rate of exchange quoted on the respective date that such transactions are recorded. The Fund does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations are included with the net realized and unrealized gain or loss from investments.

Reported net realized foreign exchange gains or losses arise from sales of foreign currencies, currency gains or losses realized between the trade and settlement dates on securities transactions, the difference between the amounts of dividends, interest and foreign withholding taxes recorded on the Fund’s books, and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses arise from changes in the value of assets and liabilities other than investments in securities at fiscal year end, resulting from changes in the exchange rate.

Other

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets, liabilities, expenses and revenues reported in the financial statements. Actual results could differ materially from those estimated. The Fund applies investment company accounting and reporting guidance.

3. SHARES OF BENEFICIAL INTEREST

The following table summarizes share activity:

	Six Months Ended 12/31/2023	Year Ended 6/30/2023
Shares sold	331,768	1,573,768
Shares issued to shareholders in payment of distributions declared	564,142	2,323,978
Shares redeemed	(13,880,971)	(93,866,788)
NET CHANGE RESULTING FROM FUND SHARE TRANSACTIONS	(12,985,061)	(89,969,042)

4. FEDERAL TAX INFORMATION

At December 31, 2023, the cost of investments for federal tax purposes was $456,241,325. The net unrealized depreciation of investments for federal tax purposes was $12,069,733. This consists of unrealized appreciation from investments for those securities having an excess of value over cost of $5,756,085 and unrealized depreciation from investments for those securities having an excess of cost over value of $17,825,818.

As of June 30, 2023, the Fund had a capital loss carryforward of $195,748,015 which will reduce the Fund’s taxable income arising from future net realized gains on investments, if any, to the extent permitted by the Code, thereby reducing the amount of distributions to shareholders which would otherwise be necessary to relieve the Fund of any liability for federal income tax. Pursuant to the Code, these net capital losses retain their character as either short-term or long-term and do not expire.

The following schedule summarizes the Fund’s capital loss carryforwards:

Short-Term	Long-Term	Total
$44,537,568	$151,210,447	$195,748,015

5. INVESTMENT ADVISER FEE AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Adviser Fee

The Adviser, subject to the direction of the Trustees, provides investment adviser services at no fee, because all investors in the Fund are other Federated Hermes Funds, insurance company separate accounts, common or commingled trust funds or similar organizations or entities that are “accredited investors” within the meaning of Regulation D of the 1933 Act. The Adviser may voluntarily choose to reimburse certain operating expenses of the Fund. The Adviser can modify or terminate this voluntary reimbursement at any time at its sole discretion.

Semi-Annual Shareholder Report

Administrative Fee

Federated Administrative Services (FAS), under the Administrative Services Agreement, provides the Fund with administrative personnel and services. FAS does not charge the Fund a fee but is entitled to reimbursement for certain out-of-pocket expenses.

Directors’/Trustees’ and Miscellaneous Fees

Certain Officers and Trustees of the Fund are Officers and Directors or Trustees of certain of the above companies. To efficiently facilitate payment, Independent Directors’/Trustees’ fees and certain expenses related to conducting meetings of the Directors/Trustees and other miscellaneous expenses are paid by an affiliate of the Adviser which in due course are reimbursed by the Fund. These expenses related to conducting meetings of the Directors/Trustees and other miscellaneous expenses may be included in Accrued and Miscellaneous Expenses on the Statement of Assets and Liabilities and Statement of Operations, respectively.

Affiliated Shares of Beneficial Interest

As of December 31, 2023, a majority of the shares of beneficial interest outstanding are owned by other affiliated investment companies.

6. INVESTMENT TRANSACTIONS

Purchases and sales of investments, excluding long-term U.S. government securities and short-term obligations, for the six months ended December 31, 2023, were as follows:

Purchases	$77,086,176
Sales	$185,333,351

7. LINE OF CREDIT

The Fund participates with certain other Federated Hermes Funds, on a several basis, in an up to $500,000,000 unsecured, 364-day, committed, revolving line of credit (LOC) agreement dated June 21, 2023. The LOC was made available to temporarily finance the repurchase or redemption of shares of the Fund, failed trades, payment of dividends, settlement of trades and for other short-term, temporary or emergency general business purposes. The Fund cannot borrow under the LOC if an inter-fund loan is outstanding. The Fund’s ability to borrow under the LOC also is subject to the limitations of the Act and various conditions precedent that must be satisfied before the Fund can borrow. Loans under the LOC are charged interest at a fluctuating rate per annum equal to (a) the highest, on any day, of (i) the federal funds effective rate, (ii) the published secured overnight financing rate plus an assigned percentage, and (iii) 0.0%, plus (b) a margin. Any fund eligible to borrow under the LOC pays its pro rata share of a commitment fee based on the amount of the lenders’ commitment that has not been utilized, quarterly in arrears and at maturity. As of December 31, 2023, the Fund had no outstanding loans. During the six months ended December 31, 2023, the Fund did not utilize the LOC.

8. INTERFUND LENDING

Pursuant to an Exemptive Order issued by the Securities and Exchange Commission, the Fund, along with other funds advised by subsidiaries of Federated Hermes, Inc., may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from other participating affiliated funds. As of December 31, 2023, there were no outstanding loans. During the six months ended December 31, 2023, the program was not utilized.

9. INDEMNIFICATIONS

Under the Fund’s organizational documents, its Officers and Directors/Trustees are indemnified against certain liabilities arising out of the performance of their duties to the Fund (other than liabilities arising out of their willful misfeasance, bad faith, gross negligence or reckless disregard of their duties to the Fund). In addition, in the normal course of business, the Fund provides certain indemnifications under arrangements with third parties. Typically, obligations to indemnify a third party arise in the context of an arrangement entered into by the Fund under which the Fund agrees to indemnify such third party for certain liabilities arising out of actions taken pursuant to the arrangement, provided the third party’s actions are not deemed to have breached an agreed-upon standard of care (such as willful misfeasance, bad faith, gross negligence or reckless disregard of their duties under the contract). The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet arisen. The Fund does not anticipate any material claims or losses pursuant to these arrangements at this time, and accordingly expects the risk of loss to be remote.

Semi-Annual Shareholder Report

Shareholder Expense Example (unaudited)

As a shareholder of the Fund, you incur ongoing costs, including to the extent applicable, management fees, distribution (12b-1) fees and/or other service fees and other Fund expenses. This Example is intended to help you to understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds. It is based on an investment of $1,000 invested at the beginning of the period and held for the entire period from July 1, 2023 to December 31, 2023.

ACTUAL EXPENSES

The first section of the table below provides information about actual account values and actual expenses. You may use the information in this section, together with the amount you invested, to estimate the expenses that you incurred over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first section under the heading entitled “Expenses Paid During Period” to estimate the expenses attributable to your investment during this period.

HYPOTHETICAL EXAMPLE FOR COMPARISON PURPOSES

The second section of the table below provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. Thus, you should not use the hypothetical account values and expenses to estimate the actual ending account balance or your expenses for the period. Rather, these figures are required to be provided to enable you to compare the ongoing costs of investing in the Fund with other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only. Therefore, the second section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

	Beginning Account Value 7/1/2023	Ending Account Value 12/31/2023	Expenses Paid During Period1
Actual	$1,000	$1,060.60	$0.52
Hypothetical (assuming a 5% return before expenses)	$1,000	$1,024.63	$0.51

1	Expenses are equal to the Fund’s annualized net expense ratio of 0.10%, multiplied by the average account value over the period, multiplied by 184/366 (to reflect the one-half-year period).

Semi-Annual Shareholder Report

Evaluation and Approval of Advisory Contract–May 2023

Bank Loan Core Fund (the “Fund”)

At its meetings in May 2023 (the “May Meetings”), the Fund’s Board of Trustees (the “Board”), including those Trustees who are not “interested persons” of the Fund, as defined in the Investment Company Act of 1940 (the “Independent Trustees”), reviewed and unanimously approved the continuation of the investment advisory contract between the Fund and Federated Investment Management Company (the “Adviser”) (the “Contract”) for an additional one-year term. The Board’s determination to approve the continuation of the Contract reflects the exercise of its business judgment after considering all of the information and factors believed to be relevant and appropriate on whether to approve the continuation of the existing arrangement. The information, factors and conclusions that formed the basis for the Board’s approval are summarized below.

The Board considered that the Fund is distinctive in that it is designed for the efficient management of a particular asset class and is made available for investment only to other funds (each, a “Federated Hermes Fund” and, collectively the “Federated Hermes Funds”) advised by the Adviser or its affiliates (collectively, “Federated Hermes”) and a limited number of other accredited investors.

In addition, the Board considered that the Adviser does not charge an investment advisory fee for its services, although Federated Hermes may receive compensation for managing assets invested in the Fund.

Information Received and Review Process

At the request of the Independent Trustees, the Fund’s Chief Compliance Officer (the “CCO”) furnished to the Board in advance of its May Meetings an independent written evaluation of the Fund’s management fee (the “CCO Fee Evaluation Report”). The Board considered the CCO Fee Evaluation Report, along with other information, in evaluating the reasonableness of the Fund’s management fee and in determining to approve the continuation of the Contract. The CCO, in preparing the CCO Fee Evaluation Report, has the authority to retain consultants, experts or staff as reasonably necessary to assist in the performance of his duties, reports directly to the Board, and can be terminated only with the approval of a majority of the Independent Trustees. At the request of the Independent Trustees, the CCO Fee Evaluation Report followed the same general approach and covered the same topics as that of the report that had previously been delivered by the CCO in his capacity as “Senior Officer” prior to the elimination of the Senior Officer position in December 2017.

In addition to the extensive materials that comprise and accompany the CCO Fee Evaluation Report, the Board considered information specifically prepared in connection with the approval of the continuation of the Contract that was presented at the May Meetings. In this regard, in the months preceding the May Meetings, the Board requested and reviewed written responses and supporting materials prepared by Federated Hermes in response to requests posed to Federated Hermes by independent legal counsel on behalf of the Independent Trustees encompassing a wide variety of topics, including those summarized below. The Board also considered such additional matters as the Independent Trustees deemed reasonably necessary to evaluate the Contract, which included detailed information about the Fund and Federated Hermes furnished to the Board at its meetings throughout the year and in between regularly scheduled meetings on particular matters as the need arose.

The Board’s consideration of the Contract included review of materials and information covering the following matters, among others: the nature, quality and extent of the advisory and other services provided to the Fund by Federated Hermes; Federated Hermes’ business and operations; the Adviser’s investment philosophy, personnel and processes; the Fund’s investment objectives and strategies; the Fund’s short-term and long-term performance (in absolute terms, both on a gross basis and net of expenses, and relative to the Fund’s particular investment program and a group of its peer funds and/or its benchmark, as appropriate); the Fund’s fees and expenses, including the advisory fee and the overall expense structure of the Fund, with due regard for contractual or voluntary expense limitations (if any); the financial condition of Federated Hermes; the Adviser’s profitability with respect to managing the Fund; distribution and sales activity for the Fund; and the use and allocation of brokerage commissions derived from trading the Fund’s portfolio securities (if any).

The Board also considered judicial decisions concerning allegedly excessive investment advisory fees charged to other registered funds in evaluating the Contract. Using these judicial decisions as a guide, the Board observed that the following factors may be relevant to an adviser’s fiduciary duty with respect to its receipt of compensation from a fund: (1) the nature and quality of the services provided by the adviser to the fund and its shareholders, including the performance of the fund, its benchmark and comparable funds; (2) the adviser’s cost of providing the services and the profitability to the adviser of providing advisory services to the fund; (3) the extent to which the adviser may realize “economies of scale” as the fund grows larger and, if such economies of scale exist, whether they have been appropriately shared with the fund and its shareholders or the family of funds; (4) any “fall-out” benefits that accrue to the adviser because of its relationship with the fund, including research services received from brokers that execute fund trades and any fees paid to affiliates of the adviser for services rendered to the fund); (5) comparative fee and expense structures,

Semi-Annual Shareholder Report

including a comparison of management fees paid to the adviser with those paid by similar funds managed by the same adviser or other advisers as well as management fees charged to institutional and other advisory clients of the same adviser for what might be viewed as like services; and (6) the extent of care, conscientiousness and independence with which the fund’s board members perform their duties and their expertise,(including whether they are fully informed about all facts the board deems relevant to its consideration of the adviser’s services and fees. The Board noted that the Securities and Exchange Commission (“SEC”) disclosure requirements regarding the basis for a fund board’s approval of the fund’s investment advisory contract generally align with the factors listed above. The Board was guided by these factors in its evaluation of the Contract to the extent it considered them to be appropriate and relevant, as discussed further below. The Board considered and weighed these factors in light of its substantial accumulated experience in governing the Fund and working with Federated Hermes on matters relating to the oversight of the other Federated Hermes Funds.

In determining to approve the continuation of the Contract, the members of the Board reviewed and evaluated information and factors they believed to be relevant and appropriate through the exercise of their reasonable business judgment. While individual members of the Board may have weighed certain factors differently, the Board’s determination to approve the continuation of the Contract was based on a comprehensive consideration of all information provided to the Board throughout the year and specifically with respect to the continuation of the Contract. The Board recognized that its evaluation process is evolutionary and that the factors considered and emphasis placed on relevant factors may change in recognition of changing circumstances in the registered fund marketplace. The Independent Trustees were assisted throughout the evaluation process by independent legal counsel. In connection with their deliberations at the May Meetings, the Independent Trustees met separately in executive session with their independent legal counsel and without management present to review the relevant materials and consider their responsibilities under applicable laws. In addition, senior management representatives of Federated Hermes also met with the Independent Trustees and their independent legal counsel to discuss the materials and presentations furnished to the Board at the May Meetings. The Board considered the approval of the Contract for the Fund as part of its consideration of agreements for funds across the family of Federated Hermes Funds, but its approvals were made on a fund-by-fund basis.

Nature, Extent and Quality of Services

The Board considered the nature, extent and quality of the services provided to the Fund by the Adviser and the resources of Federated Hermes dedicated to the Fund. In this regard, the Board evaluated, among other things, the terms of the Contract and the range of services provided to the Fund by Federated Hermes. The Board considered the Adviser’s personnel, investment philosophy and process, investment research capabilities and resources, trade operations capabilities, experience and performance track record. The Board reviewed the qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Fund and Federated Hermes’ ability and experience in attracting and retaining qualified personnel to service the Fund. The Board considered the trading operations by the Adviser, including the execution of portfolio transactions and the selection of brokers for those transactions. The Board also considered the Adviser’s ability to deliver competitive investment performance for the Fund when compared to the Fund’s benchmark index, which was deemed by the Board to be a useful indicator of how the Adviser is executing the Fund’s investment program.

In addition, the Board considered the financial resources and overall reputation of Federated Hermes and its willingness to consider and make investments in personnel, infrastructure, technology, cybersecurity, business continuity planning and operational enhancements that are designed to benefit the Federated Hermes Funds. The Board noted that the significant acquisition of Hermes Fund Managers Limited by Federated Hermes has deepened Federated Hermes’ investment management expertise and capabilities and expanded its access to analytical resources related to environmental, social and governance (“ESG”) factors and issuer engagement on ESG matters. The Board considered Federated Hermes’ oversight of the securities lending program for the Federated Hermes Funds that engage in securities lending and noted the income earned by the Federated Hermes Funds that participate in such program. In addition, the Board considered the quality of Federated Hermes’ communications with the Board and responsiveness to Board inquiries and requests made from time to time with respect to the Federated Hermes Funds. The Board also considered that Federated Hermes is responsible for providing the Federated Hermes Funds’ officers.

The Board received and evaluated information regarding Federated Hermes’ regulatory and compliance environment. The Board considered Federated Hermes’ compliance program and compliance history and reports from the CCO about Federated Hermes’ compliance with applicable laws and regulations, including responses to regulatory developments and any compliance or other issues raised by regulatory agencies. The Board also noted Federated Hermes’ support of the Federated Hermes Funds’ compliance control structure and the compliance-related resources devoted by Federated Hermes in support of the Fund’s obligations pursuant to Rule 38a-1 under the Investment Company Act of 1940, including Federated Hermes’ commitment to respond to rulemaking and other regulatory initiatives of the SEC. The Board considered Federated Hermes’ approach to internal audits and risk management with respect to the Federated Hermes

Semi-Annual Shareholder Report

Funds and its day-to-day oversight of the Federated Hermes Funds’ compliance with their investment objectives and policies as well as with applicable laws and regulations, noting that regulatory and other developments had over time led, and continue to lead, to an increase in the scope of Federated Hermes’ oversight in this regard, including in connection with the implementation of new rules on derivatives risk management and fair valuation.

The Board also considered the implementation of Federated Hermes’ business continuity plans. In addition, the Board noted Federated Hermes’ commitment to maintaining high quality systems and expending substantial resources to prepare for and respond to ongoing changes due to the market, regulatory and control environments in which the Fund and its service providers operate.

The Board considered Federated Hermes’ efforts to provide shareholders in the Federated Hermes Funds with a comprehensive array of funds with different investment objectives, policies and strategies. The Board considered the expenses that Federated Hermes had incurred, as well as the entrepreneurial and other risks assumed by Federated Hermes, in sponsoring and providing on-going services to new funds to expand these opportunities for shareholders. The Board noted the benefits to shareholders of being part of the family of Federated Hermes Funds, which include the general right to exchange investments between the same class of shares without the incurrence of additional sales charges.

Based on these considerations, the Board concluded that it was satisfied with the nature, extent and quality of the services provided by the Adviser to the Fund.

Fund Investment Performance

The Board considered the investment performance of the Fund. In evaluating the Fund’s investment performance, the Board considered performance results in light of the Fund’s investment objective, strategies and risks. The Board considered detailed investment reports on, and the Adviser’s analysis of, the Fund’s performance over different time periods that were provided to the Board throughout the year and in connection with the May Meetings.

For the one-year, three-year and five-year periods ended December 31, 2022, the Fund underperformed its benchmark index. The Board discussed the Fund’s performance with the Adviser and recognized the efforts being taken by the Adviser in the context of other factors considered relevant by the Board.

Based on these considerations, the Board concluded that it had continued confidence in the Adviser’s overall capabilities to manage the Fund.

Fund Expenses

The Board considered that the Adviser does not charge an investment advisory fee to this Fund for its services. Because the Adviser does not charge the Fund an investment advisory fee, the Board noted that it did not consider fee comparisons to other registered funds or other types of clients of Federated Hermes to be relevant to its evaluation. The Board also considered the overall expense structure of the Fund, with due regard for contractual or voluntary expense limitations.

Profitability

The Board received and considered profitability information furnished by Federated Hermes. The Board considered that the Adviser does not charge an investment advisory fee to the Fund and noted, therefore, that the Adviser does not profit from providing advisory services to the Fund under the Contract.

The Board also reviewed information compiled by Federated Hermes comparing its profitability information to other publicly held fund management companies, including information regarding profitability trends over time. The Board recognized that profitability comparisons among fund management companies are difficult because of the variation in the type of comparative information that is publicly available, and the profitability of any fund management company is affected by numerous factors. The Board considered the CCO’s conclusion that, based on such profitability information, Federated Hermes’ profit margins did not appear to be excessive. The Board also considered the CCO’s view that Federated Hermes appeared financially sound, with the resources necessary to fulfill its obligations under its contracts with the Federated Hermes Funds.

Economies of Scale

Because of the distinctive nature of the Fund as primarily an internal product with an advisory fee of zero, the Board noted that it did not consider the assessment of whether economies of scale would be realized if the Fund were to grow to a sufficient size to be particularly relevant to its evaluation.

Other Benefits

The Board considered information regarding the compensation and other ancillary (or “fall-out”) benefits that Federated Hermes derived from its relationships with the Federated Hermes Funds.

The Board noted that an affiliate of the Adviser is entitled to reimbursement for certain out-of-pocket expense incurred in providing administrative services to the Fund.

Semi-Annual Shareholder Report

In connection with the Board’s governance of other Federated Hermes Funds, the Board noted that, in addition to receiving advisory fees under the Federated Hermes Funds’ investment advisory contracts, Federated Hermes’ affiliates also receive fees for providing other services to the Federated Hermes Funds under separate service contracts including for serving as the Federated Hermes Funds’ administrator and distributor. In this regard, the Board considered that certain of Federated Hermes’ affiliates provide distribution and shareholder services to the Federated Hermes Funds, for which they may be compensated through distribution and servicing fees paid pursuant to Rule 12b-1 plans or otherwise. The Board also received and considered information detailing the benefits, if any, that Federated Hermes may derive from its receipt of research services from brokers who execute portfolio trades for the Federated Hermes Funds.

Conclusions

The Board considered: (i) the CCO’s conclusion that his observations and the information accompanying the CCO Fee Evaluation Report show that the management fee for the Fund is reasonable; and (ii) the CCO’s recommendation that the Board approve the management fee. The Board noted that, under these circumstances, no changes were recommended to, and no objection was raised to the continuation of, the Contract by the CCO. The CCO also recognized that the Board’s evaluation of the Federated Hermes Funds’ advisory and sub-advisory arrangements is a continuing and ongoing process that is informed by the information that the Board requests and receives from management throughout the course of the year and, in this regard, the CCO noted certain items for future reporting to the Board or further consideration by management as the Board continues its ongoing oversight of the Federated Hermes Funds.

On the basis of the information and factors summarized above, among other information and factors deemed relevant by the Board, and the evaluation thereof, the Board, including the Independent Trustees, unanimously voted to approve the continuation of the Contract. The Board based its determination to approve the Contract on the totality of the circumstances and relevant factors and with a view of past and future long-term considerations. Not all of the factors and considerations identified above were necessarily deemed to be relevant to the Fund, nor did the Board consider any one of them to be determinative.

Semi-Annual Shareholder Report

Liquidity Risk Management Program–
Annual Evaluation of Adequacy and Effectiveness

In accordance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), Federated Hermes Core Trust (the Trust) has adopted and implemented a liquidity risk management program (the “Program”) for Bank Loan Core Fund (the “Fund” and collectively with the other non-money market open-end funds advised by Federated Hermes, the “Federated Hermes Funds”). The Program seeks to assess and manage the Fund’s liquidity risk. “Liquidity risk” is defined under the Liquidity Rule as the risk that the Fund is unable to meet redemption requests without significantly diluting remaining investors’ interests in the Fund. The Board of Trustees of the Trust (the “Board”) has approved the designation of each Federated Hermes Fund’s investment adviser as the administrator (the “Administrator”) for the Program with respect to that Fund. The Administrator, in turn, has delegated day-to-day responsibility for the administration of the Program to multiple Liquidity Risk Management Committees, which are comprised of representatives from certain divisions within Federated Hermes.

The Program is comprised of various components designed to support the assessment and/or management of liquidity risk, including: (1) the periodic assessment (no less frequently than annually) of certain factors that influence the Fund’s liquidity risk; (2) the periodic classification (no less frequently than monthly) of the Fund’s investments into one of four liquidity categories that reflect an estimate of their liquidity under current market conditions; (3) a 15% limit on the acquisition of “illiquid investments” (as defined under the Liquidity Rule); (4) to the extent a Fund does not invest primarily in “highly liquid investments” (as defined under the Liquidity Rule), the determination of a minimum percentage of the Fund’s assets that generally will be invested in highly liquid investments (an “HLIM”); (5) if a Fund has established an HLIM, the periodic review (no less frequently than annually) of the HLIM and the adoption of policies and procedures for responding to a shortfall of the Fund’s highly liquid investments below its HLIM; and (6) periodic reporting to the Board.

At its meetings in May 2023, the Board received and reviewed a written report (the “Report”) from the Federated Hermes Funds’ Chief Compliance Officer and Chief Risk Officer, on behalf of the Administrator, concerning the operation of the Program for the period from April 1, 2022 through March 31, 2023 (the “Period”). The Report addressed the operation of the Program and assessed the adequacy and effectiveness of its implementation, including, where applicable, the operation of any HLIM established for a Federated Hermes Fund. There were no material changes to the Program during the Period. The Report summarized the operation of the Program and the information and factors considered by the Administrator in assessing whether the Program has been adequately and effectively implemented with respect to the Federated Hermes Funds. Such information and factors included, among other things:

■ confirmation that it was not necessary for the Fund to utilize, and the Fund did not utilize, any alternative funding sources that were available to the Federated Hermes Funds during the Period, such as the Federated Hermes Funds’ interfund lending facility, redemptions in-kind, reverse repurchase agreement transactions, redemptions delayed beyond the normal T+1 settlement, but within seven days of the redemption request, and committed lines of credit;

■ the periodic classifications of the Fund’s investments into one of four liquidity categories and the methodologies and inputs used to classify the investments, including the Fund’s reasonably anticipated trade size;

■ the analysis received from a third-party liquidity assessment vendor that is taken into account in the process of determining the liquidity classifications of the Fund’s investments, and the results of the Administrator’s evaluation of the services performed by the vendor in support of this process, including the Administrator’s view that the methodologies utilized by the vendor continue to be appropriate;

■ the fact that the Fund has previously established an HLIM, information regarding the methodology in determining the HLIM and whether the HLIM continues to be appropriate and the fact that based on this review the Administrator did not recommend any reduction or other changes to the HLIM;

■ the fact that no shortfalls of the Fund’s HLIM took place during the Period, and the operation of the procedures for monitoring this limit;

■ the fact that the Fund invested no more than 15% of its assets in illiquid investments during the Period, and the operation of the procedures for monitoring this limit;

■ the fact that there were no liquidity events during the Period that materially affected the Fund’s liquidity risk;

■ the impact on liquidity and management of liquidity risk, if any, caused by extended non-U.S. market closures and confirmation that there were no issues for any of the affected Federated Hermes Funds in meeting shareholder redemptions at any time during these temporary non-U.S. market closures.

Based on this review, the Administrator concluded that the Program is operating effectively to assess and manage the Fund’s liquidity risk, and that the Program has been and continues to be adequately and effectively implemented to monitor and, as applicable, respond to the Fund’s liquidity developments.

Semi-Annual Shareholder Report

Voting Proxies on Fund Portfolio Securities

A description of the policies and procedures that the Fund uses to determine how to vote proxies, if any, relating to securities held in the Fund’s portfolio, as well as a report on “Form N-PX” of how the Fund voted any such proxies during the most recent 12-month period ended June 30, are available, without charge and upon request, by calling 1-800-341-7400, Option #4. A report on “Form N-PX” of how the Fund voted any such proxies during the most recent 12-month period ended June 30 is available via the Proxy Voting Record (Form N-PX) link associated with the Fund at FederatedHermes.com/us under the “Private Funds” section of the “Products” tab, where you will be directed to a statement of agreement that you are an “accredited investor” before proceeding. Click “I agree” to agree to the terms then you will be taken to the “Private Funds” home page where you can select the appropriate asset class or category. Select a Fund to access the “Documents” tab. Form N-PX filings are also available at the SEC’s website at sec.gov.

Quarterly Portfolio Schedule

Each fiscal quarter, the Fund will file with the SEC a complete schedule of its monthly portfolio holdings on “Form N-PORT.” The Fund’s holdings as of the end of the third month of every fiscal quarter, as reported on Form N-PORT, will be publicly available on the SEC’s website at sec.gov within 60 days of the end of the fiscal quarter upon filing. You may also access this information at FederatedHermes.com/us under the “Private Funds” section of the “Products” tab, where you will be directed to a statement of agreement that you are an “accredited investor” before proceeding. Click “I agree” to agree to the terms then you will be taken to the “Private Funds” home page where you can select the appropriate asset class or category. Select a Fund to access the “Characteristics” tab.

Semi-Annual Shareholder Report

Mutual funds are not bank deposits or obligations, are not guaranteed by any bank and are not insured or guaranteed by the U.S. government, the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency. Investment in mutual funds involves investment risk, including the possible loss of principal.

This Report is authorized for distribution to prospective investors only when preceded or accompanied by the Fund’s Private Offering Memorandum, which contains facts concerning its objective and policies, management fees, expenses and other information.

IMPORTANT NOTICE ABOUT FUND DOCUMENT DELIVERY

In an effort to reduce costs and avoid duplicate mailings, the Fund(s) intend to deliver a single copy of certain documents to each household in which more than one shareholder of the Fund(s) resides (so-called “householding”), as permitted by applicable rules. The Fund’s “householding” program covers its/their Prospectus and Statement of Additional Information, and supplements to each, as well as Semi-Annual and Annual Shareholder Reports and any Proxies or information statements. Shareholders must give their written consent to participate in the “householding” program. The Fund is also permitted to treat a shareholder as having given consent (“implied consent”) if (i) shareholders with the same last name, or believed to be members of the same family, reside at the same street address or receive mail at the same post office box, (ii) the Fund gives notice of its intent to “household” at least sixty (60) days before it begins “householding” and (iii) none of the shareholders in the household have notified the Fund(s) or their agent of the desire to “opt out” of “householding.” Shareholders who have granted written consent, or have been deemed to have granted implied consent, can revoke that consent and opt out of “householding” at any time: shareholders who purchased shares through an intermediary should contact their representative; other shareholders may call the Fund at 1-800-341-7400, Option #4.

Semi-Annual Shareholder Report

Bank Loan Core Fund

Federated Hermes Funds
4000 Ericsson Drive
Warrendale, PA 15086-7561

Federated Securities Corp., Placement Agent

CUSIP 31409N804

Q450803 (2/24)

Item 2.

Code of Ethics

Not Applicable

Item 3.

Audit Committee Financial Expert

Not Applicable

Item 4.

Principal Accountant Fees and Services

Not Applicable

Item 5.

Audit Committee of Listed Registrants

Not Applicable

Item 6.

Schedule of Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1 of this form.

(b) Not Applicable; Fund had no divestments during the reporting period covered since the previous Form N-CSR filing.

Item 7.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies

Not Applicable

Item 8.

Portfolio Managers of Closed-End Management Investment Companies

Not Applicable

Item 9.

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers

Not Applicable

Item 10.

Submission of Matters to a Vote of Security Holders

No Changes to Report

Item 11.

Controls and Procedures

(a) The registrant’s President and Treasurer have concluded that the

registrant’s disclosure controls and procedures (as defined in rule 30a-3(c) under the Act) are effective in design and operation and are sufficient to form the basis of the certifications required by Rule 30a-(2) under the Act, based on their evaluation of these disclosure controls and procedures within 90 days of the filing date of this report on Form N-CSR.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in rule 30a-3(d) under the Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

Not Applicable

Item 18.

Recovery of Erroneously Awarded Compensation

(a)

Not Applicable

(b)

Not Applicable

Item 13.

Exhibits

(a)(1) Code of Ethics- Not Applicable to this Report.

(a)(2) Certifications of Principal Executive Officer and Principal Financial Officer.

(a)(3) Not Applicable.

(b) Certifications pursuant to 18 U.S.C. Section 1350.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Registrant Federated Hermes Core Trust

By /S/ Lori A. Hensler

Lori A. Hensler

Principal Financial Officer

Date February 23, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By /S/ John B. Fisher

John B. Fisher

Principal Executive Officer

Date February 23, 2024

By /S/ Lori A. Hensler

Lori A. Hensler

Principal Financial Officer

Date February 23, 2024

1	Index classifications are based upon, and individual portfolio securities are assigned to, the classifications and sub-classifications of the Credit Suisse Leveraged Loan Index (CSLLI). Individual portfolio securities that are not included in the CSLLI are assigned to an index classification by the Fund’s Adviser.
2	For purposes of this table, index classifications which constitute less than 3.5% of the Fund’s total net assets have been aggregated under the designation “Other.”
3	Other Security Types consist of Exchange-Traded funds.
4	Cash Equivalents include any investments in money market mutual funds and/or overnight repurchase agreements.
5	Assets, other than investments in securities, less liabilities. See Statement of Assets and Liabilities.

Assets:
Investment in securities, at value including $21,755,248 of investments in affiliated holdings* (identified cost $458,580,988, including $21,745,420 of identified cost in affiliated holdings)	$444,171,592
Income receivable	4,445,584
Income receivable from affiliated holdings	115,331
Receivable for investments sold	11,839,472
Total Assets	460,571,979
Liabilities:
Payable for investments purchased	10,652,007
Payable to bank	4,075,856
Income distribution payable	3,191,064
Accrued expenses (Note 5)	116,606
Total Liabilities	18,035,533
Net assets for 50,581,927 shares outstanding	$442,536,446
Net Assets Consist of:
Paid-in capital	$657,980,248
Total distributable earnings (loss)	(215,443,802)
Total Net Assets	$442,536,446
Net Asset Value, Offering Price and Redemption Proceeds Per Share:
$442,536,446 ÷ 50,581,927 shares outstanding, no par value, unlimited shares authorized	$8.75

Investment Income:
Interest	$23,824,131
Dividends (including $452,663 received from affiliated holdings*)	757,283
TOTAL INCOME	24,581,414
Expenses:
Administrative fee (Note 5)	2,547
Custodian fees	9,052
Transfer agent fees	18,599
Directors’/Trustees’ fees (Note 5)	2,350
Auditing fees	20,681
Legal fees	5,694
Portfolio accounting fees	160,349
Printing and postage	9,849
Commitment fee	2,914
Miscellaneous (Note 5)	8,983
TOTAL EXPENSES	241,018
Net investment income	24,340,396
Realized and Unrealized Gain (Loss) on Investments and Foreign Currency Transactions:
Net realized loss on investments (including net realized gain of $3,937 on sales of investments in affiliated holdings*)	(8,992,555)
Net realized gain on foreign currency transactions	821
Net change in unrealized depreciation of investments (including net change in unrealized depreciation of $10,247 on investments in affiliated holdings*)	14,033,590
Net change in unrealized appreciation of translation of assets and liabilities in foreign currency	(744)
Net realized and unrealized gain (loss) on investments and foreign currency transactions	5,041,112
Change in net assets resulting from operations	$29,381,508

	Six Months Ended (unaudited) 12/31/2023	Year Ended 6/30/2023
Increase (Decrease) in Net Assets
Operations:
Net investment income	$24,340,396	$69,720,322
Net realized gain (loss)	(8,991,734)	(88,396,516)
Net change in unrealized appreciation/depreciation	14,032,846	72,139,812
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS	29,381,508	53,463,618
Distributions to Shareholders	(25,034,820)	(66,960,902)
Share Transactions:
Proceeds from sale of shares	2,900,000	13,980,000
Net asset value of shares issued to shareholders in payment of distributions declared	4,917,388	20,369,628
Cost of shares redeemed	(120,950,000)	(823,855,527)
CHANGE IN NET ASSETS RESULTING FROM SHARE TRANSACTIONS	(113,132,612)	(789,505,899)
Change in net assets	(108,785,924)	(803,003,183)
Net Assets:
Beginning of period	551,322,370	1,354,325,553
End of period	$442,536,446	$551,322,370

Portfolio of Investments Summary Table	1
Portfolio of Investments	2
Financial Highlights	11
Statement of Assets and Liabilities	12
Statement of Operations	13
Statement of Changes in Net Assets	14
Notes to Financial Statements	15
Shareholder Expense Example	19
Evaluation and Approval of Advisory Contract	20
Liquidity Risk Management Program– Annual Evaluation of Adequacy and Effectiveness	24
Voting Proxies on Fund Portfolio Securities	25
Quarterly Portfolio Schedule	25

Index Classification	Percentage of Total Net Assets
Technology	22.8%
Insurance - P&C	8.1%
Health Care	7.7%
Media Entertainment	5.1%
Gaming	5.0%
Packaging	4.8%
Chemicals	4.4%
Building Materials	3.9%
Industrial - Other	3.7%
Other2	28.6%
Other Security Types3	1.4%
Cash Equivalents4	4.9%
Other Assets and Liabilities - Net5	(0.4)%
Total	100%